1. Inhibition of glutamine synthetase activity prevents memory consolidation.
- Author
-
Gibbs ME, O'Dowd BS, Hertz L, Robinson SR, Sedman GL, and Ng KT
- Subjects
- Alanine pharmacology, Animals, Chickens, Dose-Response Relationship, Drug, Glutamine pharmacology, Ketoglutaric Acids pharmacology, Male, Memory drug effects, Methionine Sulfoximine antagonists & inhibitors, Neuroglia enzymology, Sodium Glutamate pharmacology, Time Factors, Avoidance Learning drug effects, Enzyme Inhibitors pharmacology, Glutamate-Ammonia Ligase pharmacology, Memory physiology, Methionine Sulfoximine pharmacology
- Abstract
Methionine sulfoximine, a specific inhibitor of the exclusively glial enzyme glutamine synthetase, was shown, at a concentration of 3.5-4.5 mM, to prevent consolidation of memory for a passive avoidance task in day-old chicks. Provided the drug was administered 5-20 min before the learning task, significant retention loss was observed from the normal time of onset of the second of three postulated stages in the memory formation sequence but the drug had to be administered considerably earlier. The amnestic effect of methionine sulfoximine was successfully counteracted by L-glutamine (10 mM) and monosodium glutamate (4 mM), and also by a cocktail of alpha-ketoglutarate (5 mM) and alanine (5 mM). This effect of methionine sulfoximine is attributed to its blockade of the production of glutamine via the glutamate-glutamine cycle, leading to a reduced capacity of neurons to replenish their transmitter glutamate.
- Published
- 1996
- Full Text
- View/download PDF